Renal medullary carcinoma, or RMC, is a rare yet aggressive type of kidney cancer. It usually affects young people -- mostly those who have sickle cell disease or sickle cell trait and have ...

CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced ...

There could be new hope on the horizon for kidney cancer patients in the form of an experimental vaccine. Researchers at Dana-Farber Cancer Institute, Harvard Medical School, Yale Cancer Center ...

In a groundbreaking early-phase trial, a personalized vaccine triggered a powerful immune response in nine patients with advanced kidney cancer, successfully wiping out the disease and keeping it ...

Patterns of "speckles" in the heart of tumor cells could help predict how patients with a common form of kidney cancer will respond to different treatment options, according to research.

R enal cell carcinoma is the most common form of kidney cancer. It can take time to fully process a diagnosis and what, ...

Dr. Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ctDNA. Among patients with metastatic renal cell carcinoma (mRCC), serial ...

In kidney cancer, the cells become malignant (cancerous) and grow out of control, forming a tumor. Almost all kidney cancers ...

There could be new hope on the horizon for kidney cancer patients in the form of an experimental vaccine. Researchers at Dana-Farber Cancer Institute, Harvard Medical School, Yale Cancer Center ...